Statins may be cost-effective for a wide range of subgroups. Commentary

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)326-329
Number of pages4
JournalEvidence-based Cardiovascular Medicine
Volume9
Issue number4
DOIs
Publication statusPublished - Dec 2005

Fingerprint

Hydroxymethylglutaryl-CoA Reductase Inhibitors
Costs and Cost Analysis

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Statins may be cost-effective for a wide range of subgroups. Commentary. / Kempler, P.

In: Evidence-based Cardiovascular Medicine, Vol. 9, No. 4, 12.2005, p. 326-329.

Research output: Contribution to journalArticle

@article{09cc9bc408a34738b677b28df40bdadd,
title = "Statins may be cost-effective for a wide range of subgroups. Commentary",
author = "P. Kempler",
year = "2005",
month = "12",
doi = "10.1016/j.ebcm.2005.09.010",
language = "English",
volume = "9",
pages = "326--329",
journal = "Evidence-based Cardiovascular Medicine",
issn = "1361-2611",
publisher = "Churchill Livingstone",
number = "4",

}

TY - JOUR

T1 - Statins may be cost-effective for a wide range of subgroups. Commentary

AU - Kempler, P.

PY - 2005/12

Y1 - 2005/12

UR - http://www.scopus.com/inward/record.url?scp=28344445278&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=28344445278&partnerID=8YFLogxK

U2 - 10.1016/j.ebcm.2005.09.010

DO - 10.1016/j.ebcm.2005.09.010

M3 - Article

VL - 9

SP - 326

EP - 329

JO - Evidence-based Cardiovascular Medicine

JF - Evidence-based Cardiovascular Medicine

SN - 1361-2611

IS - 4

ER -